Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Cellectis SA (ALCLS FP)
Watchlist
2
Analysis
Health Care
•
France
Cellectis SA is a biopharmaceutical company focused on developing immunotherapies based on gene edited CAR-T cells (UCART). The company's mission is to develop a new generation of cancer therapies based on engineered T-cells.
more
Watchlist
Filings
Presentations
Events
Refresh
Exchange Announcement •
04 Nov 2022 20:30
Q3 2022
Attachment
Exchange Announcement •
05 Aug 2022 10:13
Q2 2022
Attachment
Exchange Announcement •
13 May 2022 19:50
Q1 2022
Attachment
Exchange Announcement •
04 Mar 2022 10:37
Q4 2021
Attachment
Exchange Announcement •
05 Nov 2021 08:00
Q3 2021
Attachment
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.44.4
x